- Home
- »
- Nutraceuticals & Functional Foods
- »
-
Nicotinamide Adenine Dinucleotide Products Market Report 2033GVR Report cover
Nicotinamide Adenine Dinucleotide Products Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Oral Supplements, Topical Products), By Distribution Channel (Supermarkets & Hypermarkets, Pharmacies & Drug Stores, Online), By Region, And Segment Forecasts
Market Size, 2025
$3.9BMarket Estimate, 2026
$4.5BMarket Forecast, 2033
$12.2BCAGR, 2026–2033
15.2%Nicotinamide Adenine Dinucleotide Products Market Summary
The global nicotinamide adenine dinucleotide products market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.5 billion in 2026 to USD 12.2 billion in 2033, at a CAGR of 15.2% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest revenue share of 58.9% in 2025. The demand for nicotinamide adenine dinucleotide (NAD) products is rising due to increasing awareness of their role in cellular energy production, DNA repair, and healthy aging.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By product: The oral supplement market held the largest share of 72.1% in 2025.
- By distribution channel: The online channel held the largest share of 57.8% in 2025.
Regional Highlights
- Largest regional market: Asia Pacific (58.9% revenue share, 2025)
- By country: China held the largest market share in 2025
Key Market Trends & Insights
- Market size in 2025: USD 3.9 Billion
- Estimated market size in 2026: USD 4.5 Billion
- Projected market size by 2033: USD 12.2 Billion
- CAGR (2026-2033): 15.2%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. In addition, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets. Demand for NAD products is growing due to rising awareness of their role in energy production, cellular repair, and overall metabolic health. As people become more focused on proactive health and aging well, NAD is gaining attention as a key molecule that supports the body’s natural functions, especially as NAD levels decline with age.
To learn more about this report, Download Free Sample Report The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.
NAD products also see wider use beyond supplements-appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service. Available in all 50 states after consultation with a licensed provider, the cream is dispensed in 15 mL or 30 mL pump bottles. It contains 10% nicotinamide adenine dinucleotide (NAD+), a molecule essential for cellular energy, and is prepared by licensed 503A compounding pharmacies for topical use.
Market Dynamics
The aging population and rising focus on healthy aging, preventive health, and longevity are strengthening demand for NAD⁺-based products. Consumers are increasingly seeking solutions that support energy, cognitive function, cellular health, and physical vitality, while growing interest in biohacking, personalized nutrition, and performance wellness is expanding awareness of NAD⁺ and its precursors, including NMN and NR.
Companies are responding with targeted formulations positioned around healthy aging and cellular wellness, alongside emerging applications in topical and clinical settings. For instance, Eternum Labs introduced its NAD Ultra and NMN Ultra supplements as part of an anti-aging product line, reflecting the expansion of NAD⁺-focused formulations aimed at longevity and wellness. This convergence of demographic demand, consumer education, and product innovation is creating a broader commercial opportunity for NAD⁺ across the longevity and preventive health ecosystem.
One major factor restraining market growth is the regulatory uncertainty surrounding key NAD precursors, particularly Nicotinamide Mononucleotide (NMN). While some countries, such as the U.S., allow NAD-related compounds, such as Nicotinamide Riboside (NR), to be marketed as dietary supplements, the classification and legal status of NMN remain inconsistent globally. For instance, in 2023, China banned NMN supplements, stating that the ingredient would now be subject to pharmaceutical regulation. This move not only disrupted supply chains and product offerings but also created hesitation among other regulatory bodies, which may follow similar restrictions.
This fragmented regulatory environment creates significant compliance risks and go-to-market barriers for brands operating in or expanding into international markets. Companies must navigate different sets of requirements for labeling, ingredient approvals, health claims, and product testing in each jurisdiction. The lack of global consensus also increases costs for product development, legal reviews, and reformulation efforts, especially for smaller or emerging brands that lack in-house regulatory resources. As a result, many firms delay entry into complex markets like the EU or shift focus to countries with clearer regulatory paths, limiting overall market penetration.
In addition, regulatory instability can undermine consumer trust and industry credibility. When ingredients like NMN face sudden bans or are flagged by regulatory agencies, consumers may become skeptical of NAD products as a whole, regardless of scientific support. This uncertainty can lead to hesitation at the point of purchase, especially for new users unfamiliar with the science behind NAD. Without standardized global guidelines and clear regulatory pathways, the NAD industry risks stagnation in its efforts to scale and diversify across regions and consumer segments.
The NAD products market presents opportunities driven by rising consumer interest in healthy aging, longevity, cellular health, and energy support, backed by growing research on NAD+ and its roles in cellular and mitochondrial functions. Demand is also expanding beyond conventional supplements into skincare, cognitive wellness, functional beverages, and clinical wellness applications, creating scope for product diversification. Companies can further capture demand through innovative delivery formats, including liposomal formulations, time-release capsules, topical products, and combination formulas with antioxidants or adaptogens. For instance, in March 2026, Niagen Bioscience launched its Niagen Skincare Innovation Lab and introduced Niagen NanoCloud, a waterless, precision-dose topical containing its NAD+ precursor NR. The format is designed to address stability challenges associated with NAD-related ingredients in water-based skincare. Geographic expansion across Europe, South Korea, and Southeast Asia also offers potential as awareness of longevity and preventive wellness increases, particularly among affluent and aging consumers.
Analyst Perspective
The market is evolving beyond research applications, supported by rising interest in healthy aging, cellular energy, mitochondrial health, and preventive wellness. Commercial activity is increasingly centered on NAD⁺ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), alongside emerging pharmaceutical and clinical research applications. Innovation is focusing on bioavailability, delivery formats, combination formulations, and application-specific products. However, clinical evidence remains an important market consideration, as research has demonstrated improvements in NAD-related biomarkers more consistently than definitive benefits for longevity or broader health outcomes. Consequently, clinical substantiation, product quality, regulatory compliance, and formulation differentiation are expected to remain key factors influencing market development and competitive positioning.
Consumer Insights
Consumer preferences in the NAD+ market are shifting toward healthy aging, sustained energy, cognitive wellness, and cellular health, with consumers increasingly viewing NAD+ and its precursors, such as NMN and NR, as longevity-oriented wellness solutions rather than conventional supplements. At the same time, scientific evidence, product transparency, safety, dosage clarity, and perceived efficacy are becoming more important in purchase decisions as consumers become more cautious about exaggerated anti-aging claims. Demand is also shifting toward convenient, personalized formats, including capsules, powders, sublingual products, and functional formulations tailored to specific wellness goals. Overall, the market is transitioning from biohacking and anti-aging hype toward evidence-based, personalized, and health span-focused positioning.
Product Insights
The oral supplement market accounted for the largest share of revenue at 72.1% in 2025. The oral supplements segment of the NAD products market is primarily driven by the rising consumer awareness regarding the health benefits of NAD, a crucial coenzyme involved in cellular energy metabolism and anti-aging processes. Capsules and tablets remain the most popular oral dosage forms due to their convenience, precise dosing, and extended shelf life. Consumers prefer these formats for their ease of use and portability, making them suitable for daily supplementation routines. In addition, pharmaceutical advancements have improved the bioavailability of NAD precursors in capsule and tablet forms, further boosting demand. For instance, in November 2025, Niagen Bioscience launched Tru Niagen Beauty, an oral NAD+ precursor supplement containing its patented nicotinamide riboside (NR), as well as astaxanthin, hyaluronic acid, grape seed extract, and biotin. The capsule-based formulation demonstrates how NAD-related ingredients can be incorporated into convenient daily oral supplements and combined with additional wellness benefits, supporting product diversification in the oral NAD supplement segment.
Topical is projected to grow at the fastest CAGR of 16.7% from 2026 to 2033. Topical products such as creams and serums are a significant market growth due to increasing consumer demand for effective anti-aging and skin-repair solutions. The advancements in formulation technology have improved the stability and skin penetration of NAD in topical products, further fueling their adoption. For instance, in May 2025, Eden launched a prescription-only topical NAD product- a face cream, enhancing skin resilience and cellular wellness. It contains 10% of nicotinamide adenine dinucleotide (NAD+) and is available in 15 ml and 30 ml in a pump bottle for convenience.
Distribution Channel Insights
The online channel accounts for the largest share of 57.8% in 2025. Online distribution is the fastest-growing channel for NAD products, driven by the convenience of home delivery, wide product selection, and access to detailed product information and customer reviews. E-commerce platforms, both specialized health websites and general marketplaces, enable consumers to compare prices, research ingredients, and purchase directly from NAD product manufacturers or third-party sellers. Online platforms allow consumers to read through the product reviews before making purchases.
In addition, online channels particularly benefit niche and emerging NAD brands, which can bypass the high costs of traditional retail and directly engage with consumers through digital marketing and social media. This environment allows for rapid product launches, personalized advertising, and direct customer feedback, all of which are crucial for market growth and innovation in the NAD space. Subscriptions and bundle offers also encourage repeat purchases, enhancing brand loyalty. Furthermore, international reach through online platforms enables NAD product companies to scale quickly across borders, reaching health-conscious consumers in regions with limited physical retail infrastructure. This borderless accessibility is especially important as global interest in longevity, biohacking, and anti-aging science continues to grow.
To learn more about this report, Download Free Sample Report The pharmacies and drug stores channel in the market is projected to grow at the fastest CAGR of 14.3% from 2026 to 2033. Pharmacists' recommendations can significantly influence purchase decisions, especially among older adults and individuals managing chronic health conditions seeking preventive wellness solutions. Drug stores also often stock NAD products that include therapeutic claims or formulations targeting specific health issues such as cognitive function, energy restoration, or metabolic support, making them attractive for more medically inclined consumers.
In addition, many pharmacies are expanding their wellness sections to include anti-aging and nutraceutical products, further integrating NAD offerings into their core inventory. The availability of both over-the-counter and professional-grade NAD supplements at these outlets makes them a key distribution channel for brands aiming to capture both mainstream and premium markets.
Regional Insights
The nicotinamide adenine dinucleotide products market in the Asia Pacific held the largest revenue share of 58.9% in 2025 and is projected to grow at the fastest CAGR of 17.1% from 2026 to 2033. The market is gaining momentum as rising health awareness, growing interest in longevity, preventive wellness, and cellular health drive demand. Japan and South Korea offer strong potential due to their established beauty, functional nutrition, and healthy aging markets, while China benefits from its large consumer base and an expanding premium wellness segment. Growing e-commerce penetration is improving product accessibility, and manufacturers are introducing innovative formulations combining NAD precursors with complementary ingredients, creating opportunities for product differentiation and broader consumer adoption across the region.
To learn more about this report, Download Free Sample Report China Nicotinamide Adenine Dinucleotide Products Market Trends
The nicotinamide adenine dinucleotide products market in China led the Asia-Pacific market in 2025, holding the largest market share at 70.8% of the region’s total revenue. supported by rising consumer interest in healthy aging, longevity, preventive wellness, and cellular health. China’s large and increasingly health-conscious consumer base, combined with growing demand for premium functional nutrition and wellness products, is creating opportunities for NAD-related products. The expansion of e-commerce and digital health platforms is further improving access to NAD supplements and NAD precursor products, while manufacturers are developing formulations that combine NAD precursors with complementary vitamins, antioxidants, and other functional ingredients. Growing interest in premium wellness and personalized nutrition is expected to support product innovation and broader adoption of NAD-focused solutions in China.
North America Nicotinamide Adenine Dinucleotide Products Market Trends
The nicotinamide adenine dinucleotide products market in North America is projected to grow at a CAGR of 12.4% from 2026 to 2033. The market is supported by increasing consumer interest in preventive health, healthy aging, cellular wellness, and longevity, particularly in the U.S., where demand for science-backed wellness solutions is expanding alongside the aging population. The region also benefits from the presence of wellness clinics, biotechnology companies, and research institutions investigating NAD+ and its potential role in cellular energy, metabolic health, and age-related wellness. For instance, in June 2025, Life Extension expanded its healthy-aging portfolio with the launch of FLORASSIST Probiotic Youthful Gut, a probiotic and postbiotic supplement positioned around healthy aging. The product was added to a portfolio that already includes NAD+ Cell Regenerator, illustrating how supplement companies are broadening their offerings around cellular health and longevity.
The U.S. nicotinamide adenine dinucleotide products market led North America in 2025, holding the largest market share with 91.8% of the region’s total revenue. The U.S. NAD products market is benefiting from growing consumer and professional interest in healthy aging, cellular health, energy, and longevity-focused wellness, supported by the expanding presence of NAD+ precursors across both dietary supplements and clinical wellness applications. The market is also evolving beyond conventional oral products as companies explore prescription-based and intravenous delivery formats, creating additional avenues for product diversification. For instance, in March 2025, Niagen Bioscience reported that its Niagen Plus portfolio, featuring pharmaceutical-grade nicotinamide riboside (NR) in IV and injectable formulations, was available by prescription through more than 475 clinics across the U.S. This expansion illustrates the growing integration of NAD-related solutions into U.S. wellness and clinical settings and provides companies with opportunities to address consumers seeking more specialized longevity and cellular-health solutions.
Europe Nicotinamide Adenine Dinucleotide Products Market Trends
The nicotinamide adenine dinucleotide products market in Europe is projected to grow at a CAGR of 11.0% from 2026 to 2033. The market is being supported by evolving consumer preferences that extend beyond traditional healthy-aging applications. Sports and performance are emerging as an opportunity area, with active consumers showing interest in cellular energy, endurance, and recovery-focused nutrition. At the same time, the growing convergence of beauty and wellness is creating demand for NAD-related ingredients in anti-aging skincare and beauty-from-within products. E-commerce expansion is further improving access to specialized NAD products, enabling consumers across European markets to compare formulations, ingredients, and product claims. In addition, premium products may combine NAD precursors with complementary ingredients such as antioxidants, resveratrol, or compounds targeting specific wellness goals, while offering sophisticated formats and positioning for professional or longevity clinics. Consequently, premiumization creates opportunities for brands to differentiate through science, ingredient quality, formulation technology, traceability, and targeted health benefits, rather than competing primarily on price.
The UK nicotinamide adenine dinucleotide products marketled Europe in 2025, holding the largest market share with 26.5% of the region’s total revenue. The UK NAD products market is benefiting from increasing consumer awareness of preventive healthcare, healthy aging, and wellness, which is supporting interest in NAD supplements and related products. Demand is growing across both consumer and clinical settings, with dietary supplements gaining visibility and NAD-related approaches being explored in healthcare and wellness services. In addition, the UK’s strong biomedical research ecosystem, biotechnology capabilities, and focus on health innovation provide a supportive environment for research into NAD and its potential applications, contributing to the broader market's development.
Central & South America Nicotinamide Adenine Dinucleotide Products Market Trends
The nicotinamide adenine dinucleotide products market in CSA is projected to grow at a CAGR of 9.8% from 2026 to 2033. The adoption of NAD supplements in Central & South America is influenced by the growing number of wellness centers, clinics, and fitness-oriented communities that are promoting health optimization and anti-aging treatments. With South America's rapidly expanding middle class, the demand for NAD products is expected to continue its upward trajectory as consumers seek out products that offer improved vitality, cognitive function, and longevity.
Middle East & Africa Nicotinamide Adenine Dinucleotide Products Market Trends
The nicotinamide adenine dinucleotide products market in MEA is expected to grow at a CAGR of 14.8% from 2026 to 2033. The market is gaining traction as rising health and wellness awareness and growing interest in longevity and preventive healthcare encourage consumers to explore premium wellness solutions. The UAE represents a particularly attractive market, supported by its affluent consumer base, advanced healthcare infrastructure, and strong demand for high-end, science-oriented health products. NAD-related supplements and therapies are increasingly aligned with the region’s premium wellness and longevity trend, particularly among consumers seeking solutions related to energy, cognitive wellness, and healthy aging. In addition, the UAE’s expanding medical tourism and luxury healthcare ecosystem creates opportunities for NAD-based clinical and wellness services, while the development of specialized longevity clinics and personalized health programs can further support market adoption.
Key Nicotinamide Adenine Dinucleotide Products Company Insights
The market is characterized by several key players, including both established multinational corporations and regional companies. These firms are focusing on a range of strategies to strengthen their position, such as forming strategic partnerships, collaborating with research institutions, and expanding their product portfolios to meet growing consumer demand for health and wellness products.
Key Nicotinamide Adenine Dinucleotide Products Companies
The following key companies have been profiled for this study on the nicotinamide adenine dinucleotide products market.
-
Niagen Bioscience, Inc.
-
Elysium Health
-
Thorne
-
Cata-Kor NAD
-
Life Extension
-
Wonderfeel
-
Nutricost
-
RENUE BY SCIENCE, Inc.
-
Codeage LLC
-
HPN SUPPLEMENTS
-
Core Med Science
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Niagen Bioscience, Inc.; Elysium Health; Thorne; Life Extension; RENUE BY SCIENCE, Inc.)
Focus on science-backed NAD+ supplementation, clinical research, proprietary or differentiated NAD precursors, product-line expansion, and direct-to-consumer distribution.
Strong scientific positioning, established brands, differentiated NAD+ formulations, and broad portfolios, supported by Niagen’s NR research and established NAD-focused offerings from Elysium, Thorne, Life Extension, and Renue.
Premium positioning can increase price sensitivity among consumers, while reliance on emerging NAD+ science creates challenges around substantiating long-term health and longevity claims.
Emerging Players (Cata-Kor NAD; Wonderfeel; Nutricost; Codeage LLC; HPN Supplements; Core Med Science)
Emphasize differentiated delivery systems, targeted longevity positioning, digital-first marketing, specialized formulations, and convenient supplement formats.
Greater flexibility and niche positioning support rapid responses to demand for longevity and cellular health. Cata-Kor focuses on liposomal NAD+/NMN, Wonderfeel on Youngr NMN, and Core Med Science on physician-formulated liposomal products.
Lower brand recognition and distribution reach, coupled with strong competition from established brands, may limit market penetration.
Recent Developments
-
In June 2025, Life Extension expanded its line of healthy aging supplements with new products designed to promote overall vitality and longevity. This expansion focuses on enhancing nutritional support for aging individuals through scientifically backed ingredients. FLORASSIST Probiotic Youthful Gut is the latest product to join Life Extension's comprehensive healthy aging range, which also features the popular NAD+ Cell Regenerator and the premium Optimized Resveratrol Elite.
-
In June 2025, Codeage LLC introduced Liposomal Spermidine + NAD⁺ as part of its new Helix liposomal delivery line, offering a potent, autophagy-supporting formulation of spermidine alongside 500 mg of NAD⁺ and betaine to support cellular energy and metabolic health.
-
In May 2025, Timebeam Beauty, a new skin longevity brand founded by Dr. Lamees Hamdan, launched with a focus on NAD+ boosters. The brand's initial product line includes two topicals (Skinbeam Milky Serum, Moisture Melt Serum Balm) and two ingestibles (Bounce Mode Healthy Pixie, Reset Mode Healthy Pixie).
-
In March 2025, Wonderfeel partnered with TrueMed to enhance accessibility to its premium wellness supplements through TrueMed's platform. This collaboration aims to offer customers a streamlined experience in purchasing science-backed, healthy aging products. Through this collaboration, more than 36 million HSA/FSA account holders nationwide can now access Wonderfeel products with an average savings of 30%.
Nicotinamide Adenine Dinucleotide Products Market Report Scope
Report Attribute
Details
Market size in 2025
USD 3.9 billion
Estimated market size in 2026
USD 4.5 billion
Projected market size by 2033
USD 12.2 billion
Growth rate (revenue)
CAGR of 15.2% from 2026 to 2033
Actuals
2021 - 2025
Forecast period
2026 - 2033
Quantitative (Revenue) units
Revenue in USD billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, distribution channel, region
Regional scope
North America; Europe; Asia Pacific; CSA; MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; China; Japan; India; Australia & New Zealand; Taiwan; South Korea; Brazil; UAE
Key companies profiled
Niagen Bioscience, Inc.; Elysium Health; Thorne; Cata-Kor NAD; Life Extension; Wonderfeel; Nutricost; RENUE BY SCIENCE, Inc.; Codeage LLC; HPN SUPPLEMENTS; Core Med Science
Customization scope
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Nicotinamide Adenine Dinucleotide Products Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide products market report based on product, distribution channel, and region:
To learn more about this report, Download Free Sample Report -
Product Outlook (Revenue, USD Billion, 2021 - 2033)
-
Oral Supplements
-
Capsules/Tablets
-
Powders
-
Energy Drinks
-
-
Topical Products
-
Creams & Serums
-
Eye Cream & Lip Balms
-
-
Others
-
-
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
-
Supermarkets & Hypermarkets
-
Pharmacies & Drug Stores
-
Online
-
Others
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia & New Zealand
-
Taiwan
-
South Korea
-
-
Central & South America
-
Brazil
-
-
Middle East & Africa
-
UAE
-
-
Research Methodology
The nicotinamide adenine dinucleotide products market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each nicotinamide adenine dinucleotide products segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Product
Revenue capture definition
Oral Supplements
This segment includes sales of NAD⁺ and NAD⁺ precursor products intended for oral consumption, such as capsules, tablets, powders, gummies, and liquid formulations.
Topical Products
This segment includes sales of NAD⁺-containing products formulated for topical application, such as creams, serums, lotions, gels, and other skin-applied formats.
Other Products
This segment includes sales of NAD⁺ products, including injectable formulations, intravenous (IV) products, and other specialized delivery formats.
Estimation Model
Layer
Focus
Key Question
Description
Consumption Profile Layer
Consumer needs
Who consumes NAD+ products?
Captures consumers purchasing NAD⁺ products for healthy aging, energy, cellular health, cognitive wellness, and preventive health.
Market Reach Layer
Market accessibility
Where are products accessible?
Covers e-commerce, DTC websites, pharmacies, specialty wellness stores, longevity clinics, and other consumer-facing channels.
Purchase & Retention Layer
Purchase & repeat behavior
What drives repeat purchases?
Focuses on product quality, formulation, scientific backing, perceived benefits, brand trust, price, and convenience influencing repeat purchases.
Value Generation Layer
Revenue generation
How is revenue generated?
Captures revenue from oral supplements, topical products, premium formulations, NAD⁺ precursors such as NR and NMN, and specialized delivery formats.
Customization Table
Client Request
Customization Delivered
Value Adds
Global nicotinamide adenine dinucleotide (NAD) market landscape assessment
Assessed market evolution, application areas, product forms, NAD precursors, emerging use cases, competitive intensity, and key growth drivers across the NAD ecosystem.
Helps identify high-potential applications, assess market maturity, and support informed market-entry and expansion strategies.
Global nicotinamide adenine dinucleotide (NAD) regulatory & food safety assessment
Reviewed regulatory frameworks, product-claim requirements, clinical evidence, safety considerations, and regulatory positioning of NAD and key precursors such as NR and NMN across priority markets.
Supports regulatory risk assessment, strengthens commercialization planning, and highlights markets with clearer pathways for product development.
Global nicotinamide adenine dinucleotide (NAD) channel & retail assessment
Assessed dietary supplement, pharmaceutical, wellness, clinical, e-commerce, specialty retail, and direct-to-consumer channels, including emerging commercialization models.
Helps identify effective routes to market, prioritize high-potential channels, and evaluate opportunities for broader product distribution.
Frequently Asked Questions About This Report
Asia Pacific held the largest share with the share of 58.9% in 2025.
Middle East & Africa is the fastest growing regional market over the forecast period.
Niagen Bioscience, Inc.; Elysium Health; Thorne; Cata-Kor NAD; Life Extension; Wonderfeel; Nutricost; RENUE BY SCIENCE, Inc.; Codeage LLC; HPN SUPPLEMENTS; Core Med Science
The oral nicotinamide adenine dinucleotide (NAD) products market accounted for the largest share of 72.1% of the revenue in 2025.
The global nicotinamide adenine dinucleotide products market size was valued at USD 3.9 billion in 2025 and is estimated at USD 4.5 billion for 2026.
Online channels held the largest share in 2025.
The global nicotinamide adenine dinucleotide products market is expected to grow at a CAGR of 15.2% from 2026 to 2033, reaching USD 12.2 billion by 2033.
Key factors that are driving the market growth include rising consumer demand for anti-aging solutions and expansion of pharmaceutical applications.
About the Author(s)
Nutraceuticals & Functional Foods Research Team
Consumer Goods · Nutraceuticals & Functional FoodsThis report was authored by the nutraceuticals & functional foods research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the nutraceuticals & functional foods segment of the consumer goods industry. All findings are based on proprietary consumer goods databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
